In vivo activity assessment of a concentrated AXO-AAV-OPMD clinical construct that simultaneously expresses anti-PABN1 shRNA and a codon optimized PABPN1
Project: Research
- Popplewell, Linda (PI)
| Status | Finished |
|---|---|
| Effective start/end date | 1/12/18 → 20/09/19 |
Funding
Axovant Sciences Inc: £194,748
ID: 36028211